CTC Alternative Strategies’s abrdn Life Sciences Investors HQL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,112
Closed -$150K 162
2023
Q4
$150K Buy
+11,112
New +$150K 0.31% 42